Reality beat their plan and they're leaning in: recent realized upside surprise, response underway, drivers still live
The model's full reasoning — Q1 2022 call → NOWe need answer YES/NO. Need analyze transcript for all three parts. Need be strict. Transcript: OPKO Q1 2022. Management discusses ModeX acquisition, BioReference, financials. Need find realized favorable surprise vs company's own expectations, response visible, cause still running. Let's parse. Jon Cohen: "Our commercial payer interactions continue to be successful with our preferred status with Aetna, which became effective on the 1st of this year. Volume in our clinical base business increased 4% versus the fourth quarter, driven by our preferred status with UnitedHealthcare and Aetna. Within our women's health business, our noninvasive prenatal testing business grew substantially up almost 16,000 samples year-over-year or a 219% increase. Our STIs... and cervical cancer business both grew year-over-year. For the first quarter of 2022, oncology was up 5% over the prior year and surpassed pre-pandemic volumes for almost all lines... Cancer Genetics... more than doubled in volume in the last 12 months. We continue to bring on additional testing with our OncoCyte investment... Regarding 4Kscore... with FDA approval... developed growth plan... Our reference business from hospitals continues to expand as we add more hospitals each month, and our partnerships continue to grow..." This is strength but no explicit "better than expected" vs company's own expectations. Maybe "surpassed pre-pandemic volumes" but not surprise vs plan. Scarlet: "It's been a little over a year since we formally introduced... delighted with progress... services now available in most of Continental US... receiving added reimbursement... over 85 million patients... significant demand... finding success... proud to announce formal relationship with Teladoc... MVP..." Again no explicit "ahead of expectations." Adam Logal: "As we discussed during our fourth quarter call, margins during the first quarter were impacted by an increase in labor costs while we manage through the surge in testing coming from the Omnicron variant as well as a significant portion of our test volume coming from our point-of-care testing channels, which have a higher cost to serve.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SFIX | Stitch Fix, Inc. | Q3 2024 | 2024-06-04 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CTRA | Coterra Energy Inc. | Q1 2024 | 2024-05-03 | A |
| CW | Curtiss-Wright Corporation | Q1 2024 | 2024-05-02 | B+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| JPM | JPMorgan Chase & Co. | Q2 2021 | 2021-07-13 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| TPB | Turning Point Brands, Inc. | Q1 2017 | 2017-05-11 | B |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| CGNX | Cognex Corporation | Q2 2016 | 2016-08-01 | A |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| SAN | Banco Santander, S.A. | Q4 2015 | 2016-01-27 | B |
TENB · Q2 2021 → YESThe question is about whether management recounts something real that turned out better than expected, and they're already responding to it, with the cause still in effect. YES The transcript shows management describing the Alsid acquisition as delivering a realized favorable surprise: customers and prospects received the identity and user permission vulnerability assessment "well received" and it led to "outperformance of our earlier expectations from the business." This concerns a real operating event (customer adoption and platform uptake) that already happened and exceeded the company's own prior expectations. Management is visibly responding by accelerating investments: they plan to continue adding quota capacity in the second half (more than in the first half) and to invest in sales and marketing, explicitly tied to the strong performance and confidence in the business.
CYBR · Q3 2021 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES Management describes a realized favorable surprise in the subscription transition: "we made strong progress and outperformed our expectations in the third quarter" and "subscription ARR growth accelerated to 131%," with "strong demand for our SaaS solutions" continuing to drive it. They are already responding visibly by accelerating the transition and realloc resources, resetting plans upward to exit by Q3 2022 instead of Q4, and raising the annual recurring revenue growth expectation from 35% to 37% based on record bookings. The cause remains in effect, as they note the acceleration and strong demand environment persisting into the year.
ET · Q2 2023 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES The transcript shows management describing a realized favorable surprise on the Enable acquisition: actual performance "exceed[s] anything that we ever expected," with results "significantly higher, a good probably 40% or 50% higher than what we were anticipating." They attribute part of the upside to ongoing commercial synergies being discovered daily as integration proceeds. Management is visibly responding by integrating the assets, actively identifying and implementing new commercial opportunities (new routes, blending, additions to move more throughput), and reallocating attention toward expanding volumes.